Mazur G - Search Results

1

Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma.

Łacina P, Butrym A, Frontkiewicz D, Mazur G, Bogunia-Kubik K. Łacina P, et al. Among authors: mazur g. Curr Issues Mol Biol. 2022 Jan 14;44(1):350-359. doi: 10.3390/cimb44010026. Curr Issues Mol Biol. 2022. PMID: 35723405 Free PMC article.

2

IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma.

Mazur G, Bogunia-Kubik K, Wróbel T, Karabon L, Polak M, Kuliczkowski K, Lange A. Mazur G, et al. Immunol Lett. 2005 Jan 31;96(2):241-6. doi: 10.1016/j.imlet.2004.08.015. Immunol Lett. 2005. PMID: 15585329

3

Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia.

Bogunia-Kubik K, Mazur G, Urbanowicz I, Wróbel T, Kuliczkowski K, Woźniak M, Lange A. Bogunia-Kubik K, et al. Among authors: mazur g. Int J Immunogenet. 2006 Feb;33(1):21-4. doi: 10.1111/j.1744-313X.2005.00553.x. Int J Immunogenet. 2006. PMID: 16426238

4

TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients.

Mazur G, Bogunia-Kubik K, Wrobel T, Kuliczkowski K, Lange A. Mazur G, et al. Cytokine. 2006 Feb 7;33(3):145-9. doi: 10.1016/j.cyto.2005.12.010. Cytokine. 2006. PMID: 16524740

5

[New trends in non-Hodgkin's lymphoma therapy].

Mazur G, Wróbel T, Jurczak W, Butrym A. Mazur G, et al. Postepy Hig Med Dosw (Online). 2006;60:707-21. Postepy Hig Med Dosw (Online). 2006. PMID: 17245320 Free article. Review. Polish.

6

Increased monocyte chemoattractant protein 1 (MCP-1/CCL-2) serum level in acute myeloid leukemia.

Mazur G, Wróbel T, Butrym A, Kapelko-Słowik K, Poreba R, Kuliczkowski K. Mazur G, et al. Neoplasma. 2007;54(4):285-9. Neoplasma. 2007. PMID: 17822317

7

Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma.

Bogunia-Kubik K, Mazur G, Wróbel T, Kuliczkowski K, Lange A. Bogunia-Kubik K, et al. Among authors: mazur g. Tissue Antigens. 2008 Feb;71(2):146-50. doi: 10.1111/j.1399-0039.2007.00984.x. Tissue Antigens. 2008. PMID: 18201362

8

IFN gamma gene polymorphism may contribute to the susceptibility to CLL.

Urbanowicz I, Mazur G, Stacherzak-Pawlik J, Bogunia-Kubik K, Wróbel T, Woźniak M, Kuliczkowski K. Urbanowicz I, et al. Among authors: mazur g. Pathol Oncol Res. 2010 Jun;16(2):213-6. doi: 10.1007/s12253-009-9209-2. Epub 2009 Sep 15. Pathol Oncol Res. 2010. PMID: 19757192 Free article.

9

Expression of bone morphogenetic proteins (BMPs) receptors in patients with B-cell chronic lymphocytic leukemia (B-CLL).

Dzietczenia J, Wróbel T, Jaźwiec B, Mazur G, Butrym A, Poręba R, Kuliczkowski K. Dzietczenia J, et al. Among authors: mazur g. Int J Lab Hematol. 2010 Dec;32(6 Pt 1):e217-21. doi: 10.1111/j.1751-553X.2010.01233.x. Int J Lab Hematol. 2010. PMID: 20491995

10

Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin's lymphoma.

Mazur G, Jaskuła E, Kryczek I, Dłubek D, Butrym A, Wróbel T, Lange A, Kuliczkowski K. Mazur G, et al. Folia Histochem Cytobiol. 2011;49(2):240-7. doi: 10.5603/fhc.2011.0033. Folia Histochem Cytobiol. 2011. PMID: 21744323 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

426 results

Search Page